Poseida Therapeutics Inc PSTX Valuation Ratios and Share Stats

S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Poseida Therapeutics Inc (PSTX)
Poseida Therapeutics Inc (PSTX) Financials

Poseida Therapeutics Inc (PSTX)

9.31

-0.02

(-0.21%)

Closed November 30 3:00PM

Delayed by 15 minutes

9.30

-0.01

(-0.11%)

After Hours: 4:00PM

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End December 30 2023	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-196.826	-90.078	-50.06	-39.006	-20.608	-39.452
Return on Equity (%)	115.759	76.495	-230.799	-59.771	-37.231	-84.745
Return on Invested Capital (%)	-737.836	-160.32	-66.105	-59.997	-28.22	-63.875
Operating Margin (%)	N/A	N/A	N/A	-389.321	-43.748	-177.197
Net Profit Margin (%)	N/A	N/A	N/A	-400.07	-49.047	-190.764
Book Value Per Share	-0.641	4.078	4.145	2.41	2.118	1.026
Earnings Per Share	-2.901	-5.258	-2.098	-1.999	-0.745	-1.291
Cash Per Share	1.986	5.334	1.357	3.3	0.947	0.465
Working Capital Per Share	1.281	6.4	4.59	2.728	2.846	1.623
Operating Profit Per Share	N/A	N/A	N/A	0.5	1.518	0.677
EBIT Per Share	-2.914	-5.258	-2.098	-1.999	-0.738	-1.29
EBITDA Per Share	-2.914	-5.258	-2.098	-1.999	-0.738	-1.29
Free Cash Flow Per Share	-2.862	-5.017	-1.866	-2.029	-0.759	-1.317

Liquidity Ratios

Year End December 30 2023	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	15.31M	16.46M	61.86M	62.52M	85.96M	N/A

Key Stats and Ratios

Year End December 30 2023	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	85.95M	85.96M	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	-355.98	N/A	N/A	N/A	-78.25	N/A
Net Profit Margin (%)	N/A	N/A	-375.587	N/A	N/A	N/A	-86.255	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	909.35M
Price to Earnings Ratio	-7.35
Price to Sales Ratio	14.02
Price to Cash Ratio	20.4
Price to Book Ratio	8.75
Dividend Yield	-

Share Statistics

Shares Outstanding	97.47M
Average Volume (1 week)	8.27M
Average Volume (1 Month)	2.22M
52 Week Change	250.00%
52 Week High	9.42
52 Week Low	1.91

More Ratios Coming Soon!

Poseida Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions